Microsoft set to launch 'plasmabot' to help recovered coronavirus patients donate plasma


The recovered patient's blood develops antibodies to battle against COVID-19.

IAS officer Vinod Rao, who is in-charge of Vadodara COVID-19 operation, said doctors, officials and community leaders persuaded these patients to donate their blood so that plasma can be extracted. "We will first collect a sample and test it before asking the patients to come to the blood bank and donate the plasma", he said, and added that collected plasma from recovered patients would be stored for use on other patients in future.

Plasma therapy is slowly but surely emerging as the best treatment to treat Covid-19 patients.

Of these 14,255 are active cases of Covid-19; 2,841 individuals have recovered and discharged from hospital and one person migrated to another country. A special medical technology called apheresis, using expensive equipment, is used to draw blood from the patient, separate the plasma out, and return the rest of the blood back into the body.

Banks made $10 billion in fees on coronavirus loans despite low risks
Treasury Secretary Steven Mnuchin said that larger companies would be prohibited from tapping the new fund for more rescue money. Public companies combined are set to receive at least $243 million in PPP loans, according to research from Morgan Stanley.

Reports said the Indian Council of Medical Research (ICMR) has received 99 applications from institutes seeking participation in a randomised controlled study to assess the safety and efficacy of convalescent plasma to limit complications associated with COVID19. While sufficient research hasn't yet been carried out to conclude whether or not treatment with plasma donations is an effective treatment for the disease, the fluid is now in high demand so that the necessary investigations can take place.

Though Mumbai has more than 400 recovered patients, only two have so far turned up to donate blood for the plasma therapy trials being carried out by the Brihanmumbai Municipal Corporation (MC).

The trial, coordinated by the Mayo Clinic, has CoxHealth treating their first patient with the plasma. We know the answer is no. Antibodies begin to form and combat infection within these patients in a matter of days.

Speaking to reporters here, he said the convalescent Plasma Therapy was only for patients who are critical, in Intensive Care Units or on ventilator. This could delay treatment for some patients, and those experiencing severe conditions might not have time to wait.